術(shù)前介入栓塞在腎臟巨大腫瘤手術(shù)中的應(yīng)用及臨床評(píng)價(jià)

本文格式為Word版，下載可任意編輯——術(shù)前介入栓塞在腎臟巨大腫瘤手術(shù)中的應(yīng)用及臨床評(píng)價(jià)

目的：對(duì)術(shù)前介入栓塞在腎臟巨大腫瘤手術(shù)中的應(yīng)用及臨床效果舉行深入分析和評(píng)價(jià)研究。方法：收集本院2022年8月-2022年8月收治的60例腎臟巨大腫瘤患者作為研究對(duì)象，按照隨機(jī)數(shù)字表法分為A組（30例，直接舉行手術(shù)治療）和B組（30例，先舉行介入栓塞治療再舉行手術(shù)治療），比較兩組患者的手術(shù)時(shí)間、術(shù)中出血量、住院時(shí)間以及并發(fā)癥發(fā)生處境等指標(biāo)。結(jié)果：B組患者的手術(shù)時(shí)間（95.25±16.27）min明顯小于A組患者的（150.66±21.44）min，B組患者的術(shù)中出血量（195.41±12.43）mL明顯小于A組患者的（640.83±11.04）mL，B組患者的住院時(shí)間（2.52±0.73）d明顯小于A組患者的（7.64±0.87）d，兩組對(duì)比差異均有統(tǒng)計(jì)學(xué)意義（P<0.05）。治療后，A組患者治療后展現(xiàn)腰痛2例，出血2例，感染3例；B組患者治療后展現(xiàn)腰痛1例，B組并發(fā)癥發(fā)生率3.33%明顯低于A組患者的23.33%，對(duì)比差異有統(tǒng)計(jì)學(xué)意義（P<0.05）。結(jié)論：術(shù)前介入栓塞在腎臟巨大腫瘤手術(shù)中有良好的應(yīng)用效果，通過術(shù)前介入栓塞，能夠有效縮短腎臟巨大腫瘤手術(shù)時(shí)間和患者的住院時(shí)間，裁減術(shù)中出血量以及相關(guān)并發(fā)癥的發(fā)生，對(duì)于提高腎臟巨大腫瘤患者的手術(shù)告成率，促進(jìn)患者后續(xù)的身體恢復(fù)有特別積極的作用。

腎臟巨大腫瘤手術(shù)；介入栓塞

TheApplicationandClinicalEvaluationofPreoperativeEmbolotherapyintheOperationofHugeRenalTumor/FENGXiao，ZHANGKaiyan，ZHOUYuming，etal.//MedicalInnovationofChina，2022，15（07）：063-066

Objective：Toanalyzeandevaluatetheapplicationandclinicaleffectofpreoperativeembolotherapyintheoperationofhugerenaltumor.Method：Atotalof60caseswhichwerediagnosedashugerenaltumorinourhospitalfromAugust2022toAugust2022randomlydividedintoAgroup（30cases，directsurgicaltreatment）andBgroup（30cases，thefirstpreoperativeembolotherapyandsurgicaltreatment）accordingtotableofrandomnumbers.Theoperationtime，bloodloss，hospitalizationtimeandcomplicationswerecomparedbetweentwogroups.Result：TheoperativetimeinBgroupwas（95.25±16.27）minsignificantlylowerthanthatingroupA（150.66±21.44）min，theamountofbleedingpatientsinBgroupwas（195.41±12.43）mLsignificantlylowerthanthatingroupA（640.83±11.04）mL，hospitalizationtimeintheBgroupwas（2.52±0.73）dlessthanthatofAgroup（7.64±0.87）d，thedifferencewasstatisticallysignificant（P<0.05）.InAgroup，therewere2casesoflumbagoaftertreatment，2casesofbleedingand3casesofinfection；1caseoflumbagoinBgroupaftertreatment，thecomplicationsrateofBgroupwas3.33%significantlylowerthanthatofAgroup23.33%，thedifferencewasstatisticallysignificant（P<0.05）.Conclusion：Preoperativeembolotherapyhasgoodapplicationeffectinhugerenaltumorsurgery.Preoperativeembolotherapyintheoperationofhugerenaltumorcaneffectivelyshortentheoperationtime，reducebloodlossandrelatedcomplications，improvesurgerysuccessrate，promotethephysicalrecoveryofpatients.

Hugerenaltumorsu